Quaternary structure, aggregation and cytotoxicity of transthyretin

Amyloid

Volumn 19, Issue SUPPL. 1, 2012, Pages 5-7

  Mizuguchi, Mineyuki ^a   Yokoyama, Takeshi ^a   Nabeshima, Yuko ^a   Kawano, Keiichi ^b   Tanaka, Ichiro ^c   Niimura, Nobuo ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c IBARAKI UNIVERSITY   (Japan)

Author keywords

Aggregation; Cytotoxicity; Hydrogen bond network; Neutron protein crystallography; Transthyretin

Indexed keywords

DIMER; MONOMER; PREALBUMIN; PROTEIN VARIANT; SERINE;

AMYLOIDOSIS; CELL DEATH; CONFERENCE PAPER; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; CYTOTOXICITY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYDROGEN BOND; NERVE CELL NETWORK; NEUROBLASTOMA CELL; NEUTRON; PH; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN QUATERNARY STRUCTURE; TUMOR CELL LINE;

AMYLOIDOSIS; CELL DEATH; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; MUTATION; PREALBUMIN; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84861440792     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.666510     Document Type: Conference Paper

References (13)

1. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057-1062. (Pubitemid 41043725)
2. Westermark P, Bergström J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003;10 Suppl 1:48-54. (Pubitemid 37372567)
3. Hamilton JA, Benson MD. Transthyretin: a review from a structural perspective. Cell Mol Life Sci 2001;58:1491-1521. (Pubitemid 32964418)
4. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160-184. (Pubitemid 37372400)
5. McCutchen SL, Colon W, Kelly JW. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 1993;32:12119-12127. (Pubitemid 23353652)
6. Colon W, Kelly JW. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992;31: 8654-8660.
7. De Lucia R, Mauro A, Di Scapio A, Buffo A, Mortara R, Orsi L, Schiffer D. A new mutation on the transthyretin gene (Ser112 to Ile) causes an amyloid neuropathy with severe cardiac impairment. Clin Neuropathol 1993;12:S44.
8. Yokoyama T, Mizuguchi M, Nabeshima Y, Kusaka K, Yamada T, Hosoya T, Ohhara T, et al. Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin. J Struct Biol 2012;177:283-290.
9. Matsubara K, Mizuguchi M, Igarashi K, Shinohara Y, Takeuchi M, Matsuura A, Saitoh T, et al. Dimeric transthyretin variant assembles into spherical neurotoxins. Biochemistry 2005;44: 3280-3288. (Pubitemid 40326263)
10. Miroy GJ, Lai Z, Lashuel HA, Peterson SA, Strang C, Kelly JW. Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc Natl Acad Sci USA 1996;93:15051-15056. (Pubitemid 27009550)
11. Niimura N, Bau R. Neutron protein crystallography: beyond the folding structure of biological macromolecules. Acta Crystallogr, A, Found Crystallogr 2008;64:12-22.
12. Tanaka I, Kusaka K, Hosoya T, Niimura N, Ohhara T, Kurihara K, Yamada T, et al. Neutron structure analysis using the IBARAKI biological crystal diffractometer (iBIX) at J-PARC. Acta Crystallogr D Biol Crystallogr 2010;66:1194-1197.
13. Palaninathan SK, Mohamedmohaideen NN, Snee WC, Kelly JW, Sacchettini JC. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. J Mol Biol 2008;382:1157-1167.